InvestorsHub Logo
Followers 16
Posts 5825
Boards Moderated 0
Alias Born 07/16/2018

Re: Cyosol post# 16161

Wednesday, 06/10/2020 11:11:41 AM

Wednesday, June 10, 2020 11:11:41 AM

Post# of 21531
WHEN IS THE COMPANY'S "PLANNED" PHASE 3 STUDY SCHEDULED TO INITIATE???????????



providing a clinical supply for the Company's planned Phase 3 study and a manufacturing alternative that delivers a dramatically superior cost of goods," stated Dr. Daniel Alkon, President and Chief Scientific Officer of Neurotrope.









Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SNPX News